Impact of Oscillating Positive Expiratory Pressure Device Use on Post-Discharge Hospitalizations: A Retrospective Cohort Study Comparing Patients with COPD or Chronic Bronchitis Using the Aerobika^® and Acapella^® Devices

References

• BienerAI, DeckerSL, RohdeF. Prevalence and treatment of Chronic Obstructive Pulmonary Disease (COPD) in the United States. JAMA. 2019;322(7):602. doi:10.1001/jama.2019.1024131429884
   PubMed Web of Science ®Google Scholar
• AnthonisenNR, ManfredaJ, WarrenCP, HershfieldES, HardingGK, NelsonNA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106(2):196–204. doi:10.7326/0003-4819-106-2-1963492164
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of COPD; 2020 Available from: https://goldcopd.org/wp-content/uploads/2019/12/GOLD-2020-FINAL-ver1.2-03Dec19_WMV.pdf. Accessed 130, 2020.
   Google Scholar
• SeemungalTA, DonaldsonGC, PaulEA, BestallJC, JeffriesDJ, WedzichaJA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(5 Pt 1):1418–1422. doi:10.1164/ajrccm.157.5.97090329603117
   PubMed Web of Science ®Google Scholar
• MiravitllesM, FerrerM, PontA, et al. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax. 2004;59(5):387–395. doi:10.1136/thx.2003.00873015115864
   PubMed Web of Science ®Google Scholar
• DonaldsonGC, SeemungalTA, BhowmikA, WedzichaJA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57(10):847–852. doi:10.1136/thorax.57.10.84712324669
   PubMed Web of Science ®Google Scholar
• JohannesdottirSA, ChristiansenCF, JohansenMB, et al. Hospitalization with acute exacerbation of chronic obstructive pulmonary disease and associated health resource utilization: a population-based Danish cohort study. J Med Econ. 2013;16(7):897–906. doi:10.3111/13696998.2013.80052523621504
   PubMedGoogle Scholar
• Soler-CatalunaJJ, Martinez-GarciaMA, Roman SanchezP, SalcedoE, NavarroM, OchandoR. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925–931. doi:10.1136/thx.2005.04052716055622
   PubMed Web of Science ®Google Scholar
• DonaldsonGC, LawM, KowlessarB, et al. Impact of prolonged exacerbation recovery in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;192(8):943–950. doi:10.1164/rccm.201412-2269OC26151174
   PubMed Web of Science ®Google Scholar
• HurstJR, VestboJ, AnzuetoA, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–1138. doi:10.1056/NEJMoa090988320843247
   PubMed Web of Science ®Google Scholar
• AbudaggaA, SunSX, TanH, SolemCT. Exacerbations among chronic bronchitis patients treated with maintenance medications from a US managed care population: an administrative claims data analysis. Int J Chron Obstruct Pulmon Dis. 2013;8:175–185. doi:10.2147/COPD.S4043723589684
   PubMed Web of Science ®Google Scholar
• ShahT, PressVG, Huisingh-ScheetzM, WhiteSR. COPD readmissions: addressing COPD in the era of value-based health care. Chest. 2016;150(4):916–926. doi:10.1016/j.chest.2016.05.00227167208
   PubMed Web of Science ®Google Scholar
• WedzichaJAE-C-C, MiravitllesM, HurstJR, et al. Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline. Eur Respir J. 2017;49(3):1600791. doi:10.1183/13993003.00791-201628298398
   PubMed Web of Science ®Google Scholar
• Nice Guideline Updates Team. National institute for health and care excellence: clinical guidelines In: Chronic Obstructive Pulmonary Disease in Over 16s: Diagnosis and Management. London: National Institute for Health and Care Excellence (UK); 2018.
   Google Scholar
• OsadnikCR, McDonaldCF, JonesAP, HollandAE. Airway clearance techniques for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2012;(3):Cd008328.22419331
   PubMed Web of Science ®Google Scholar
• VolskoTA, DiFioreJ, ChatburnRL. Performance comparison of two oscillating positive expiratory pressure devices: acapella versus flutter. Respir Care. 2003;48(2):124–130.12556253
   PubMedGoogle Scholar
• SvenningsenS, PaulinGA, SheikhK, et al. Oscillatory positive expiratory pressure in chronic obstructive pulmonary disease. COPD. 2016;13(1):66–74. doi:10.3109/15412555.2015.104352326430763
   PubMedGoogle Scholar
• BourbeauJ, McIvorRA, DevlinHM, KaplanA. Oscillating positive expiratory pressure (OPEP) device therapy in Canadian respiratory disease management: review, care gaps and suggestion for use. Can Respir Crit Care Sleep Med. 2019;3(4):233–240. doi:10.1080/24745332.2018.1558426
   Web of Science ®Google Scholar
• WolkoveN, KamelH, RotapleM, BaltzanMA Jr. Use of a mucus clearance device enhances the bronchodilator response in patients with stable COPD. Chest. 2002;121(3):702–707. doi:10.1378/chest.121.3.70211888949
   PubMed Web of Science ®Google Scholar
• SuggettJ. Quality of life (QOL) responder rate analysis following use of an oscillating positive expiratory pressure (OPEP) device for chronic obstructive pulmonary disease (COPD): SGRQV CAT assessments. Chronic Obstr Pulm Dis. 2017;4(3):237.
   Google Scholar
• WestK, WallenM, FollettJ. Acapella vs. PEP mask therapy: a randomised trial in children with cystic fibrosis during respiratory exacerbation. Physiother Theory Pract. 2010;26(3):143–149. doi:10.3109/0959398090301526820331370
   PubMedGoogle Scholar
• BurudpakdeeC, SeetasithA, DunneP, et al. A real-world study of 30-day exacerbation outcomes in Chronic Obstructive Pulmonary Disease (COPD) patients managed with Aerobika OPEP. Pulm Ther. 2017;3(1):163–171. doi:10.1007/s41030-017-0027-5
   Google Scholar
• MilanS, BondalapatiP, MegallyM, et al. Positive expiratory pressure therapy with and without oscillation and hospital length of stay for acute exacerbation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2019;14:2553–2561.31819393
   PubMed Web of Science ®Google Scholar
• Van FleetH, DunnDK, McNinchNL, VolskoTA. Evaluation of functional characteristics of 4 oscillatory positive pressure devices in a simulated cystic fibrosis model. Respir Care. 2017;62(4):451–458. doi:10.4187/respcare.0457028292973
   PubMed Web of Science ®Google Scholar
• PoncinW, ReychlerG, LiistroM, LiistroG. Comparison of 6 oscillatory positive expiratory pressure devices during active expiratory flow. Respir Care. 2019;65(4):492–499.31744866
   PubMed Web of Science ®Google Scholar
• SuggettJ, MeyerA. A laboratory assessment into the efficiency and effectiveness of different oscillating positive expiratory pressure devices by means of patient simulated expiratory waveforms. Chest. 2017;152(4):A970. doi:10.1016/j.chest.2017.08.1005
   Web of Science ®Google Scholar
• KimV, CrinerGJ. Chronic bronchitis and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(3):228–237. doi:10.1164/rccm.201210-1843CI23204254
   PubMed Web of Science ®Google Scholar
• OberNS, GrubmullerJ, FarrellM, et al. System and Method for Generating De-Identified Health Care Data. Google Patents; 2004.
   Google Scholar
• OberNS, GrubmullerJ, FarrellM, et al. System and Method for Generating De-Identified Health Care Data. Google Patents; 2008.
   Google Scholar
• ZubeldiaK, RomneyGW Anonymously Linking a Plurality of Data Records. Google Patents; 2002.
   Google Scholar
• NazirSA, ErblandML. Chronic obstructive pulmonary disease: an update on diagnosis and management issues in older adults. Drugs Aging. 2009;26(10):813–831.19761275
   PubMed Web of Science ®Google Scholar
• StuartEA, LeeBK, LeacyFP. Prognostic score-based balance measures can be a useful diagnostic for propensity score methods in comparative effectiveness research. J Clin Epidemiol. 2013;66(8 Suppl):S84–S90.e81. doi:10.1016/j.jclinepi.2013.01.01323849158
   PubMed Web of Science ®Google Scholar
• RoosLL, StrancL, JamesRC, LiJ. Complications, comorbidities, and mortality: improving classification and prediction. Health Serv Res. 1997;32(2):229–238.9180617
   PubMed Web of Science ®Google Scholar
• ReilevM, PottegårdA, LykkegaardJ, SøndergaardJ, IngebrigtsenTS, HallasJ. Increased risk of major adverse cardiac events following the onset of acute exacerbations of COPD. Respirology. 2019;24(12):1183–1190. doi:10.1111/resp.1362031222861
   PubMed Web of Science ®Google Scholar
• MenzinJ, BoulangerL, MartonJ, et al. The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population. Respir Med. 2008;102(9):1248–1256.18620852
   PubMed Web of Science ®Google Scholar
• HarknessH, PatrickC, LefebvreJ Survey of patients using an oscillating positive expiratory pressure device indicates improvement in well-being and compliance to therapy. Paper presented at: Canadian Respiratory Conference; 423–25, 2015; Ottawa, Ontario.
   Google Scholar
• JohnsonML, CrownW, MartinBC, DormuthCR, SiebertU. Good research practices for comparative effectiveness research: analytic methods to improve causal inference from nonrandomized studies of treatment effects using secondary data sources: the ISPOR good research practices for retrospective database analysis task force report–part III. Value Health. 2009;12(8):1062–1073.19793071
   PubMed Web of Science ®Google Scholar
• BarkerR, LavertyAA, HopkinsonNS. Adjuncts for sputum clearance in COPD: clinical consensus versus actual use. BMJ Open Respir Res. 2017;4(1):e000226. doi:10.1136/bmjresp-2017-000226
   PubMed Web of Science ®Google Scholar